Surgical Management of Hidradenitis Suppurativa: A 14-Year Retrospective Review of 98 Consecutive Patients

Kathleen Romanowski, Alice Fagin, Bridget Werling, Gretchen Kass, Junlin Liao, Thomas Granchi, Gerald P. Kealey, Lucy Wibbenmeyer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hidradenitis suppurativa (HS) is a debilitating suppurative disease of the apocrine/follicular glands. Medical treatment has some efficacy in early-stage disease but is costly and requires frequent physician visits. Advanced disease usually requires surgical intervention. This treatment has not been well described in the literature. We sought to review our experience with HS treatment in a large surgical cohort. A retrospective review of 98 consecutive HS patients from 2000 to 2014 was performed. A two-stage operative approach was used. The first stage involved the removal of all the hair-bearing skin in the affected areas down to healthy tissue followed by the application of split-thickness skin grafts 48 to 72 hours later. Descriptive statistics were performed to describe the population and assess outcomes. The study population was young (36 ± 12 years) and predominately female (65, 66%). The patients were obese (body mass index, 36 ± 8.3 kg/m) and smokers (73, 73.7%). The majority presented with axillary disease (73%). There were 144 debridement procedures and 146 grafting procedures performed with a mean area grafted being 416 ± 500 cm (90–3400 cm). Only nine (9%) required regrafting, with the mean area regrafted being 140 ± 93 cm. Graft failure of less than 30% did not require regrafting. At 30 days after the initial procedure, 94.7% of all wounds were fully grafted and closed. Advanced stages of HS require ablation of the infected distorted glands for control of recurrent infections. Ablative excision of HS-affected skin and wound closure with split-thickness skin grafts is a safe, reliable, and effective therapy.

Original languageEnglish (US)
JournalJournal of Burn Care and Research
DOIs
StateAccepted/In press - Mar 15 2017
Externally publishedYes

Fingerprint

Hidradenitis Suppurativa
Skin
Transplants
Apocrine Glands
Hair Removal
Wounds and Injuries
Debridement
Therapeutics
Infection Control
Population
Body Mass Index
Physicians

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Rehabilitation

Cite this

Surgical Management of Hidradenitis Suppurativa : A 14-Year Retrospective Review of 98 Consecutive Patients. / Romanowski, Kathleen; Fagin, Alice; Werling, Bridget; Kass, Gretchen; Liao, Junlin; Granchi, Thomas; Kealey, Gerald P.; Wibbenmeyer, Lucy.

In: Journal of Burn Care and Research, 15.03.2017.

Research output: Contribution to journalArticle

Romanowski, Kathleen ; Fagin, Alice ; Werling, Bridget ; Kass, Gretchen ; Liao, Junlin ; Granchi, Thomas ; Kealey, Gerald P. ; Wibbenmeyer, Lucy. / Surgical Management of Hidradenitis Suppurativa : A 14-Year Retrospective Review of 98 Consecutive Patients. In: Journal of Burn Care and Research. 2017.
@article{a9a9ddfb84d24a219c35e5a11892be83,
title = "Surgical Management of Hidradenitis Suppurativa: A 14-Year Retrospective Review of 98 Consecutive Patients",
abstract = "Hidradenitis suppurativa (HS) is a debilitating suppurative disease of the apocrine/follicular glands. Medical treatment has some efficacy in early-stage disease but is costly and requires frequent physician visits. Advanced disease usually requires surgical intervention. This treatment has not been well described in the literature. We sought to review our experience with HS treatment in a large surgical cohort. A retrospective review of 98 consecutive HS patients from 2000 to 2014 was performed. A two-stage operative approach was used. The first stage involved the removal of all the hair-bearing skin in the affected areas down to healthy tissue followed by the application of split-thickness skin grafts 48 to 72 hours later. Descriptive statistics were performed to describe the population and assess outcomes. The study population was young (36 ± 12 years) and predominately female (65, 66{\%}). The patients were obese (body mass index, 36 ± 8.3 kg/m) and smokers (73, 73.7{\%}). The majority presented with axillary disease (73{\%}). There were 144 debridement procedures and 146 grafting procedures performed with a mean area grafted being 416 ± 500 cm (90–3400 cm). Only nine (9{\%}) required regrafting, with the mean area regrafted being 140 ± 93 cm. Graft failure of less than 30{\%} did not require regrafting. At 30 days after the initial procedure, 94.7{\%} of all wounds were fully grafted and closed. Advanced stages of HS require ablation of the infected distorted glands for control of recurrent infections. Ablative excision of HS-affected skin and wound closure with split-thickness skin grafts is a safe, reliable, and effective therapy.",
author = "Kathleen Romanowski and Alice Fagin and Bridget Werling and Gretchen Kass and Junlin Liao and Thomas Granchi and Kealey, {Gerald P.} and Lucy Wibbenmeyer",
year = "2017",
month = "3",
day = "15",
doi = "10.1097/BCR.0000000000000531",
language = "English (US)",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Surgical Management of Hidradenitis Suppurativa

T2 - A 14-Year Retrospective Review of 98 Consecutive Patients

AU - Romanowski, Kathleen

AU - Fagin, Alice

AU - Werling, Bridget

AU - Kass, Gretchen

AU - Liao, Junlin

AU - Granchi, Thomas

AU - Kealey, Gerald P.

AU - Wibbenmeyer, Lucy

PY - 2017/3/15

Y1 - 2017/3/15

N2 - Hidradenitis suppurativa (HS) is a debilitating suppurative disease of the apocrine/follicular glands. Medical treatment has some efficacy in early-stage disease but is costly and requires frequent physician visits. Advanced disease usually requires surgical intervention. This treatment has not been well described in the literature. We sought to review our experience with HS treatment in a large surgical cohort. A retrospective review of 98 consecutive HS patients from 2000 to 2014 was performed. A two-stage operative approach was used. The first stage involved the removal of all the hair-bearing skin in the affected areas down to healthy tissue followed by the application of split-thickness skin grafts 48 to 72 hours later. Descriptive statistics were performed to describe the population and assess outcomes. The study population was young (36 ± 12 years) and predominately female (65, 66%). The patients were obese (body mass index, 36 ± 8.3 kg/m) and smokers (73, 73.7%). The majority presented with axillary disease (73%). There were 144 debridement procedures and 146 grafting procedures performed with a mean area grafted being 416 ± 500 cm (90–3400 cm). Only nine (9%) required regrafting, with the mean area regrafted being 140 ± 93 cm. Graft failure of less than 30% did not require regrafting. At 30 days after the initial procedure, 94.7% of all wounds were fully grafted and closed. Advanced stages of HS require ablation of the infected distorted glands for control of recurrent infections. Ablative excision of HS-affected skin and wound closure with split-thickness skin grafts is a safe, reliable, and effective therapy.

AB - Hidradenitis suppurativa (HS) is a debilitating suppurative disease of the apocrine/follicular glands. Medical treatment has some efficacy in early-stage disease but is costly and requires frequent physician visits. Advanced disease usually requires surgical intervention. This treatment has not been well described in the literature. We sought to review our experience with HS treatment in a large surgical cohort. A retrospective review of 98 consecutive HS patients from 2000 to 2014 was performed. A two-stage operative approach was used. The first stage involved the removal of all the hair-bearing skin in the affected areas down to healthy tissue followed by the application of split-thickness skin grafts 48 to 72 hours later. Descriptive statistics were performed to describe the population and assess outcomes. The study population was young (36 ± 12 years) and predominately female (65, 66%). The patients were obese (body mass index, 36 ± 8.3 kg/m) and smokers (73, 73.7%). The majority presented with axillary disease (73%). There were 144 debridement procedures and 146 grafting procedures performed with a mean area grafted being 416 ± 500 cm (90–3400 cm). Only nine (9%) required regrafting, with the mean area regrafted being 140 ± 93 cm. Graft failure of less than 30% did not require regrafting. At 30 days after the initial procedure, 94.7% of all wounds were fully grafted and closed. Advanced stages of HS require ablation of the infected distorted glands for control of recurrent infections. Ablative excision of HS-affected skin and wound closure with split-thickness skin grafts is a safe, reliable, and effective therapy.

UR - http://www.scopus.com/inward/record.url?scp=85015883739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015883739&partnerID=8YFLogxK

U2 - 10.1097/BCR.0000000000000531

DO - 10.1097/BCR.0000000000000531

M3 - Article

C2 - 28328662

AN - SCOPUS:85015883739

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

ER -